Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
10/2003
10/07/2003US6630345 Isolated DNA soup from amino acid sequence 1 or 2
10/07/2003US6630337 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
10/07/2003US6630331 Isolated DNA encoding a protein from Lotus japonicus which has pantothenate synthetase activity; enzyme inhibitors
10/07/2003US6630329 Generating a library of mutant nucleotide sequences; obtain nucleotide sequences, incubate with primers, amplification reaction mixture and inosine, amplify, recover mutant nucleotide sequences
10/07/2003US6630327 Methods and reagents for preparing and using immunological agents specific for P-glycoprotein
10/07/2003US6630326 Cancer diagnosis and therapy based on mutations in TGF-β receptors
10/07/2003US6630318 Prognostic evaluation of cancer
10/07/2003US6630316 Method for measurement of lymphocyte function
10/07/2003US6630315 Adsorbing bacterial toxins by contacting with a material having an immobilizing carrier; use in detecting exotoxins in blood and urine and in treatment of sepsis and autoimmune diseases
10/07/2003US6630314 Noninvasive detection of colorectal cancer and other gastrointestinal pathology
10/07/2003US6630312 Method for identifying compounds for treatment of insulin resistance
10/07/2003US6630311 Fluorescence-based high throughput screening assays for protein kinases and phosphatases
10/07/2003US6630310 Assay for binding between carbohydrate and glycolipid
10/07/2003US6630309 Determination of an analyte in a liquid medium
10/07/2003US6630308 Generating preferential amino acid sequences on substrate; obtain substrate, deblock, expose to amino acids, recover preferential particles
10/07/2003US6630307 Chemical and biological targets having an affinity for the nanocrystal which emits upon radiation a charateristic emission spectrum analyzed spectroscopically; immunoassays; ELIZA; accuracy; noncontamination
10/07/2003US6630304 Human osteoporosis gene
10/07/2003US6630298 HCV antigen/antibody combination assay
10/07/2003US6630297 Methods of screening for agents that modulate the interaction of human ECT2 polypeptide with an ECT2 binding target
10/07/2003US6630296 Monitoring the activity of preferential enzymes; obtain sample containing enzymes, incubate with substrate, monitor adjustment in enzyme activity
10/07/2003US6630006 Generating crystal structure of preferential protein; form layouts, obtain protein, incubate in mother liquor solution, allow crystals to form, generate images of cystal drops
10/07/2003US6629934 Indirect calorimeter for medical applications
10/07/2003US6629933 Using oxygen sensor to determine minimum value of oxygen partial pressure in exhaled air per respiratory cycle, determining, as maximum value of carbon dioxide in exhaled air, difference between that value and pressure in inhaled air
10/07/2003US6629919 Core for blood processing apparatus
10/07/2003US6629451 Method for determining the rheology of a gelled fluid
10/07/2003US6629444 Method and apparatus for diagnosing gas sensors
10/07/2003CA2280290C Netrin receptors
10/07/2003CA2223418C Polyoxyhydrocarbyl related products and methods for fluorescence assays
10/07/2003CA2221522C Quenching reagents and assays for enzyme-mediated luminescence
10/07/2003CA2211204C Prostaglandin receptor dp
10/07/2003CA2188612C Improved method for the detection of protein in urine
10/07/2003CA2141451C Photoactivatable chemiluminescent matrices
10/07/2003CA2132540C A monoclonal antibody to a human mdr1 multidrug resistance gene product, and uses
10/07/2003CA2084532C Methods for preventing air injection into a detection chamber supplied with injected liquid
10/07/2003CA2074153C Seroreactive regions on hpv 16 proteins e1 and e2
10/07/2003CA2068471C Reagent and method for analyzing cells in urine
10/07/2003CA1341442C Transgenic animals
10/02/2003WO2003081509A2 DATA MINING OF SNP DATABASES FOR THE SELECTION OF INTRAGENIC SNPs
10/02/2003WO2003081506A2 Method of visualizing non-targeted metabolomic data generated from fourier transform ion cyclotron resonance mass spectrometers
10/02/2003WO2003081471A1 Apparatus for managing gene expression data
10/02/2003WO2003081261A2 Microdevices having a preferential axis of magnetization and uses thereof
10/02/2003WO2003081259A2 Methods of using alpha 1b-adrenergic receptors
10/02/2003WO2003081258A2 Diagnostics and therapeutics for diseases associated with growth hormone secretagogue receptor (ghs)
10/02/2003WO2003081257A2 Diagnostics and therapeutics for diseases associated with neuropeptide ff receptor 1 (npff1)
10/02/2003WO2003081256A2 Diagnostics and therapeutics for diseases associated with human g protein-coupled orphan receptor 21 (gpr21)
10/02/2003WO2003081255A1 Method of analyzing peptide for determining c-terminal amino acid sequence
10/02/2003WO2003081254A1 Protein profiling of hyper acidic plants
10/02/2003WO2003081253A2 Electrochemical multi-well plate
10/02/2003WO2003081252A1 Arrays
10/02/2003WO2003081251A1 Novel compositions and methods in cancer associated with altered expression of prdm 11
10/02/2003WO2003081250A1 Novel compositions and methods in cancer associated with altered expression of prlr
10/02/2003WO2003081249A2 Method for the detection of prion proteins
10/02/2003WO2003081248A1 Screening method for gastritis
10/02/2003WO2003081247A2 Method for clearing color and debris from a chromotographic test strip
10/02/2003WO2003081245A1 Method, system and computer program for detecting molecular binding interactions comprising response curve quality control
10/02/2003WO2003081244A2 Method of electrochemical cell analysis
10/02/2003WO2003081243A1 Fluorescent polarization method, kit used therefor and biosensor
10/02/2003WO2003081242A1 Caspr3: modulators of angiogenesis
10/02/2003WO2003081241A1 Attachment of biomolecules to hydrophobic surfaces
10/02/2003WO2003081240A1 Method of judging viral infection
10/02/2003WO2003081239A2 Treating cancer
10/02/2003WO2003081238A2 Cytocapacity test
10/02/2003WO2003081237A1 Detection and isolation of cell populations from muscle using antibodies to fa1/dlk1
10/02/2003WO2003081236A2 Method and device for predicting cardiovascular events
10/02/2003WO2003081234A2 Diagnostics and therapeutics for diseases associated with homo sapiens g - protein - coupled receptor 8 (gpr8)
10/02/2003WO2003081233A1 Method and apparatus for simulating pvt parameters
10/02/2003WO2003081232A1 Device and method for detecting characteristics of liquids
10/02/2003WO2003081231A1 Method and device for calibrating a humidity sensor and sensor arrangement comprising a humidity sensor that can be calibrated
10/02/2003WO2003081230A1 Optical imaging of nanostructured substrates
10/02/2003WO2003081229A1 Method of assaying coenzymes a in biological sample
10/02/2003WO2003081223A2 Sensors with variable response behavior
10/02/2003WO2003081217A1 Method for evaluating the photosynthetic activity of a plant and, in case of perturbation, for identifying the deficiencies in particular nutritional and device therefor
10/02/2003WO2003081215A1 Method and apparatus for storing and dispensing reagents
10/02/2003WO2003081211A2 Discrete bayesian analysis of data
10/02/2003WO2003081210A2 Identification of kinase inhibitors
10/02/2003WO2003081209A2 Identification of ligands for a receptor family and related methods
10/02/2003WO2003081208A2 Improvements in pharmaceutical discovery and development
10/02/2003WO2003081206A2 Stratification of patient populations having or suspected of having rheumatoid arthritis
10/02/2003WO2003081204A2 Microscale sensor element and related device and method of manufacture
10/02/2003WO2003081203A2 Csf biomarker dilution factor corrections by mri imaging and algorithm
10/02/2003WO2003081202A2 Bioconjugate-nanoparticle probes
10/02/2003WO2003081201A2 Peripheral blood cell markers useful for diagnosing multiple sclerosis and methods and kits utilizing same
10/02/2003WO2003080869A2 Storing and detecting nucleic acid administered to a solid carrier
10/02/2003WO2003080864A1 Histone deacetylase: novel molecular target of neurotoxicity
10/02/2003WO2003080860A1 A quick and sensitive method of quantifying mycolic acid
10/02/2003WO2003080858A2 Screening assay
10/02/2003WO2003080857A2 Pna oligomers, oligomers sets, methods and kits pertaining to the detection of bacillus anthracis
10/02/2003WO2003080856A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
10/02/2003WO2003080853A1 Novel compositions and methods in cancer associated with altered expression of tbx21
10/02/2003WO2003080852A1 Process for the preparation of a desired erythropoietin glyco-isoform profile
10/02/2003WO2003080840A1 A method of inspecting the genetic susceptibility of h.pylori related gastric carcinoma and the use of it
10/02/2003WO2003080831A1 Nuclear receptor errϝ3
10/02/2003WO2003080829A1 Dna trap/release apparatus using channel and method of trapping and releasing dna
10/02/2003WO2003080823A2 Bacteriophages useful for therapy and prophylaxis of bacterial infections
10/02/2003WO2003080808A2 Novel compositions and methods in cancer
10/02/2003WO2003080805A2 Kinases and phosphatases
10/02/2003WO2003080793A2 Treating solution containing aluminium ion for staining protein and staining method using the same
10/02/2003WO2003080792A2 Use of urea-adjuvated polypeptides for diagnosis, prophylaxis and treatment
10/02/2003WO2003080789A1 Device and method for detecting cellular processes by means of luminescence measurements
10/02/2003WO2003080743A2 Stabilized inorganic particles
1 ... 2493 2494 2495 2496 2497 2498 2499 2500 2501 2502 2503 2504 2505 2506 2507 2508 2509 2510 2511 2512 2513 ... 3937